Interfering residues narrow the spectrum of MLV restriction by human TRIM5α
2007

How TRIM5α Recognizes Murine Leukemia Virus

publication Evidence: moderate

Author Information

Author(s): Maillard Pierre V, Reynard Séverine, Serhan Fatima, Turelli Priscilla, Trono Didier

Primary Institution: Global Health Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

Hypothesis

Can mutations in TRIM5α expand its ability to restrict different strains of murine leukemia virus (MLV)?

Conclusion

Mutations in TRIM5α can broaden its antiviral activity to include B-MLV and Mo-MLV, demonstrating a direct interaction between TRIM5α and the viral capsid.

Supporting Evidence

  • Mutations at tyrosine336 in TRIM5α expanded its activity to B-MLV and Mo-MLV.
  • The study demonstrated that specific residues on the viral capsid influence its sensitivity to TRIM5α.
  • The research supports a model of direct binding between TRIM5α and the viral capsid.

Takeaway

Scientists found that changing a tiny part of a protein called TRIM5α helps it fight off more types of viruses. This is like giving a superhero new powers to stop more bad guys.

Methodology

The study involved creating mutant forms of TRIM5α and testing their ability to restrict different strains of MLV in cell lines.

Limitations

The study primarily focused on specific mutations and may not account for all possible variations in TRIM5α or MLV.

Digital Object Identifier (DOI)

10.1371/journal.ppat.0030200

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication